2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxylate manufacturers
|
| 2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxylate Basic information |
Product Name: | 2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxylate | Synonyms: | 2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxylate;1,6-Naphthyridine-3-carboxylic acid, 4-(4-cyano-2-methoxyphenyl)-1,4,5,6-tetrahydro-2,8-dimethyl-5-oxo-, 2-cyanoethyl ester;2-Cyanoethyl 4-(4-cyano-2-methoxyphenyl)-1,4,5,6-tetrahydro-2,8-dimethyl-5-oxo-1,6-naphthyridine-3-carboxylate;1,6-Naphthyridine-3-carboxylic acid, 4-(4-cyano-2-methoxyphenyl)-1,4,5,6-tetrahydro-2,8-dimethyl-5-oxo-, 2-cyanoethyl ester (ACI);Finelidone Impurity 52;2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-terahydro-1,6-naphthyridine-3-carboxylate | CAS: | 1050477-43-4 | MF: | C22H20N4O4 | MW: | 404.42 | EINECS: | 810-149-0 | Product Categories: | Intermediate | Mol File: | 1050477-43-4.mol |  |
| 2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxylate Chemical Properties |
vapor pressure | 0.006Pa at 25℃ | Water Solubility | 6.2mg/L at 20℃ | InChI | InChI=1S/C22H20N4O4/c1-12-11-25-21(27)19-18(15-6-5-14(10-24)9-16(15)29-3)17(13(2)26-20(12)19)22(28)30-8-4-7-23/h5-6,9,11,18,26H,4,8H2,1-3H3,(H,25,27) | InChIKey | YUBVPYQJGHKIIA-UHFFFAOYSA-N | SMILES | N1C2=C(C(=O)NC=C2C)C(C2=CC=C(C#N)C=C2OC)C(C(OCCC#N)=O)=C1C | LogP | 0.97 |
| 2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxylate Usage And Synthesis |
Uses | 2-Cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxylate is a pharmaceutical intermediary ingredient used in the preparation of Finerenone. Finerenone is a non-steroidal, selective salicorticosteroid receptor (MR) antagonist that is used to reduce the risk of serious renal and cardiac problems (e.g., decreased kidney function, end-stage renal disease, cardiovascular death, heart attack, and hospitalisation for heart failure) in patients with chronic kidney disease associated with type 2 diabetes mellitus. | Flammability and Explosibility | Not classified |
| 2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxylate Preparation Products And Raw materials |
|